Amy L. Burroughs, Chief Executive Officer at Terns Pharmaceuticals, Inc. (TERN), sold 137,498 shares at $37.02 ($5.1M) on 2026-01-15, disclosed to the SEC on 2026-01-16.
Open-market sale of $5.1M TERN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.02 | 61,228 | $2.3M | 44.5% |
| 2 | $37.02 | 61,228 | $2.3M | 44.5% |
| 3 | $37.53 | 7,521 | $282K | 5.5% |
| 4 | $37.53 | 7,521 | $282K | 5.5% |
| Total | $37.07 avg | 137,498 | $5.1M | 100% |
| Filing → |
| TERN | SELL | 2026-01-06 | $5.4M | — | Filing → |
| TERN | BUY | 2025-06-25 | $180K | — | Filing → |
| TERN | BUY | 2025-02-03 | $3K | — | Filing → |